Emmessar Biotech & Nutrition Limited (524768) fair value: what the stock is really worth
As of Nov 17, 2026: fair value (intrinsic value) of Emmessar Biotech & Nutrition Limited stock ₹23.66, price ₹28.39, that is 16.7% below the price, quality 67 out of 100. Rating: overvalued. Calculated from audited financials with 17 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Emmessar Biotech & Nutrition Limited
524768 · BSEExpensive (fair value 17% below the price) and falling price, but solid company: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range ₹19.15 – ₹62.61 · fair‑value band ₹22.24 – ₹39.14 · the ₹28.39 price screens above the ₹23.66 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether Emmessar Biotech & Nutrition is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Emmessar Biotech & Nutrition Limited, a healthcare company, manufactures and markets healthcare and nutritional products in India and internationally. It operates through Healthcare, Fine Chemicals, and Rent on Lease Land segments.
Show moreShow less
The company offers bone care, general health, muscle care, pain relief, sexual health, skin care, and skin cure products. The company was formerly known as Emmessar Chemical Industries Ltd. and changed its name to Emmessar Biotech & Nutrition Limited in April 2000.
Emmessar Biotech & Nutrition Limited was founded in 1992 and is headquartered in Mumbai, India.
Stock analysis
Emmessar Biotech & Nutrition Limited (524768) currently trades at ₹28.39, while our model-based Fair Value estimate is ₹23.66, 17% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹29.81 per share, and 4 of the 17 models we run sit above the ₹28.39 price.
Bear case: the Multiples group reads lowest at ₹10.90, and 13 of the 17 models stay below the price. Data coverage for this calculation is low.
Scenario range: ₹22.24 (bear) to ₹39.14 (bull), the price of ₹28.39 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 67/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Emmessar Biotech & Nutrition Limited reported revenue of ₹3.7M in FY2026 versus ₹3.6M in FY2022, a compound +0.4%/yr. Reported net income was ₹4.4M in FY2026, compounding −2.1%/yr from FY2022.
Key figures
Market cap ₹142M (≈ $1.5M) Micro · P/E ratio 19.9 · P/S ratio 2.55 · EPS (TTM) ₹0.7660 · Net margin 12.8% · Return on assets (EBIT) −12.5% (5-year average) · Operating margin 17.3% · Revenue growth (YoY) −78.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 55 out of 100 (low confidence).
What moves the price
The share trades about 12% below its 52-week high and 42% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −28% fair-value upside, at −17%, 524768 screens cheaper than that median.
Fair Value models
All 17 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
524768 screens overvalued: fair value 17% below the price. Compare with Merck KGaA →
Compare Emmessar Biotech & Nutrition Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 605 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on equity by industry
- Quality Score by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.48 | $113.53 | +36% | vs 524768 |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥47.66 | ¥53.04 | +11% | vs 524768 |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,870 | ₹1,983 | +6% | vs 524768 |
| Haleon plc HLN | $9.05 | $8.47 | −6% | vs 524768 |
| Merck KGaA MRK | €150.75 | €108.83 | −28% | vs 524768 |
| Galderma Group GALD | CHF 187.15 | CHF 112.46 | −40% | vs 524768 |
| Takeda Pharmaceutical Company TAK | $21.64 | $11.23 | −48% | vs 524768 |
| Sandoz Group SDZ | CHF 83.00 | CHF 40.54 | −51% | vs 524768 |
| Teva Pharmaceutical Industries Limited TEVA | $42.62 | $20.74 | −51% | vs 524768 |
| Divi's Laboratories Limited DIVISLAB | ₹11,150 | ₹1,567 | −86% | vs 524768 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Emmessar Biotech & Nutrition Limited (524768) overvalued or undervalued?
What is the fair value of 524768?
What is the quality score of 524768?
What is the price target for Emmessar Biotech & Nutrition Limited (524768)?
What is the Emmessar Biotech & Nutrition Limited stock forecast for 2026?
What growth is priced into Emmessar Biotech & Nutrition Limited (524768)?
What discount rate (WACC) does the fair value of 524768 use?
What is a reverse DCF?
How much growth has Emmessar Biotech & Nutrition Limited (524768) delivered so far?
How fast is the sector of Emmessar Biotech & Nutrition Limited (524768) growing?
What is the free cash flow yield of Emmessar Biotech & Nutrition Limited (524768)?
What is the intrinsic value of Emmessar Biotech & Nutrition Limited (524768)?
Is Emmessar Biotech & Nutrition Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 524768?
How much is Emmessar Biotech & Nutrition Limited worth?
What do the bullish and bearish scenarios say about 524768?
What is the P/E ratio of 524768?
How far is 524768 from its 52-week high?
Which stocks are comparable to Emmessar Biotech & Nutrition Limited?
Is Emmessar Biotech & Nutrition Limited stock attractive at the current price?
How is the fair value of 524768 calculated?
Is it still worth investing in stocks now?
What is the share price of Emmessar Biotech & Nutrition Limited (524768)?
What should I pay attention to with Emmessar Biotech & Nutrition Limited right now?
Key figures of Emmessar Biotech & Nutrition Limited
How large is the market capitalisation of Emmessar Biotech & Nutrition Limited (524768)?
What is the P/S ratio of Emmessar Biotech & Nutrition Limited (524768)?
What are the earnings per share of Emmessar Biotech & Nutrition Limited (524768)?
What is the net margin of Emmessar Biotech & Nutrition Limited (524768)?
What is the EBIT return on assets of Emmessar Biotech & Nutrition Limited (524768)?
What is the operating margin of Emmessar Biotech & Nutrition Limited (524768)?
How fast is revenue growing at Emmessar Biotech & Nutrition Limited (524768)?
How fast are earnings growing at Emmessar Biotech & Nutrition Limited (524768)?
How much net debt does Emmessar Biotech & Nutrition Limited (524768) carry?
Watch Emmessar Biotech & Nutrition Limited in the live analysis
One click puts Emmessar Biotech & Nutrition Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.